These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8739199)

  • 41. Enhanced susceptibility to periodontitis in an animal model of depression: reversed by chronic treatment with the anti-depressant tianeptine.
    Breivik T; Gundersen Y; Myhrer T; Fonnum F; Osmundsen H; Murison R; Gjermo P; von Hörsten S; Opstad PK
    J Clin Periodontol; 2006 Jul; 33(7):469-77. PubMed ID: 16820034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression.
    Guan SZ; Liu JW; Fang EF; Ng TB; Lian YL; Ge H
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):414-22. PubMed ID: 24448466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression.
    Gigliucci V; Gormley S; Gibney S; Rouine J; Kerskens C; Connor TJ; Harkin A
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1349-61. PubMed ID: 24931298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression.
    Yang D; Li Q; Fang L; Cheng K; Zhang R; Zheng P; Zhan Q; Qi Z; Zhong S; Xie P
    Neuroscience; 2011 Sep; 192():609-18. PubMed ID: 21722712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The differential effects of depression on evoked and spontaneous pain behaviors in olfactory bulbectomized rats.
    Wang W; Qi WJ; Xu Y; Wang JY; Luo F
    Neurosci Lett; 2010 Mar; 472(2):143-7. PubMed ID: 20138969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulated arachidonic acid signalling in the olfactory bulbectomized rat model of depression.
    Skelin I; Kovačević T; Sato H; Diksic M
    Neurochem Int; 2011 Mar; 58(4):483-8. PubMed ID: 21211542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats.
    Greisen MH; Bolwig TG; Wörtwein G
    Behav Brain Res; 2005 Jun; 161(2):204-12. PubMed ID: 15922046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Aspirin and Dexamethasone against Experimentally Induced Depression in Rats.
    Bhatt S; Shukla P; Raval J; Goswami S
    Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):10-8. PubMed ID: 26645736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat.
    Morales-Medina JC; Dominguez-Lopez S; Gobbi G; Beck-Sickinger AG; Quirion R
    Behav Brain Res; 2012 Aug; 233(2):298-304. PubMed ID: 22613731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antidepressant-like action of the bark ethanolic extract from Tabebuia avellanedae in the olfactory bulbectomized mice.
    Freitas AE; Machado DG; Budni J; Neis VB; Balen GO; Lopes MW; de Souza LF; Veronezi PO; Heller M; Micke GA; Pizzolatti MG; Dafre AL; Leal RB; Rodrigues AL
    J Ethnopharmacol; 2013 Feb; 145(3):737-45. PubMed ID: 23237932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stressor-induced alterations in serotonergic activity in an animal model of depression.
    Connor TJ; Song C; Leonard BE; Anisman H; Merali Z
    Neuroreport; 1999 Feb; 10(3):523-8. PubMed ID: 10208583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of antiasthenic drug ladasten on the level of cytokines and behavior in experimental model of anxious depression in C57BL/6 male mice].
    Tallerova AV; Kovalenko LP; Durnev AD; Seredenin SB
    Eksp Klin Farmakol; 2011; 74(11):3-5. PubMed ID: 22288152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a distinct neuro-immune signature in rats that develop behavioural disability after nerve injury.
    Austin PJ; Berglund AM; Siu S; Fiore NT; Gerke-Duncan MB; Ollerenshaw SL; Leigh SJ; Kunjan PA; Kang JW; Keay KA
    J Neuroinflammation; 2015 May; 12():96. PubMed ID: 25986444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurokinin-1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression.
    Roche M; Kerr DM; Hunt SP; Kelly JP
    Behav Brain Res; 2012 Mar; 228(1):91-8. PubMed ID: 22155476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral and neurochemical characterization of maternal care effects on juvenile Sprague-Dawley rats.
    Masís-Calvo M; Sequeira-Cordero A; Mora-Gallegos A; Fornaguera-Trías J
    Physiol Behav; 2013 Jun; 118():212-7. PubMed ID: 23711565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways.
    Holzmann I; da Silva LM; Corrêa da Silva JA; Steimbach VM; de Souza MM
    Pharmacol Biochem Behav; 2015 Sep; 136():55-63. PubMed ID: 26196245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
    Aydin M; Yilmaz B; Alcin E; Nedzvetsky VS; Sahin Z; Tuzcu M
    Neuroscience; 2008 Jan; 151(1):186-94. PubMed ID: 18061360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression.
    Wrynn AS; Mac Sweeney CP; Franconi F; Lemaire L; Pouliquen D; Herlidou S; Leonard BE; Gandon J; de Certaines JD
    Brain Res; 2000 Oct; 879(1-2):193-9. PubMed ID: 11011022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
    Ramamoorthy R; Radhakrishnan M; Borah M
    Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.